v3.26.1
Condensed Consolidated Statement of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   14,854,725    
Beginning balance at Dec. 31, 2024 $ 310,375 $ 0 $ 572,673 $ (262,298)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense 4,048   4,048  
Common stock issued upon exercise of stock options (in shares)   1,683    
Common stock issued upon exercise of stock options 19   19  
Common stock issued upon vesting of restricted stock units (in shares)   73,158    
Net loss (22,647)     (22,647)
Ending balance (in shares) at Mar. 31, 2025   14,929,566    
Ending balance at Mar. 31, 2025 $ 291,795 $ 0 576,740 (284,945)
Beginning balance (in shares) at Dec. 31, 2025 15,489,800 15,489,800    
Beginning balance at Dec. 31, 2025 $ 264,887 $ 0 617,536 (352,649)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense $ 3,629   3,629  
Common stock issued upon exercise of stock options (in shares) 21,324 21,324    
Common stock issued upon exercise of stock options $ 201   201  
Common stock issued upon vesting of restricted stock units (in shares)   104,662    
Net loss $ (30,934)     (30,934)
Ending balance (in shares) at Mar. 31, 2026 15,615,786 15,615,786    
Ending balance at Mar. 31, 2026 $ 237,783 $ 0 $ 621,366 $ (383,583)